Takayuki Nakagawa
0000-0002-6247-3191
Publication & Citation Trends
Publications
45 total
A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component PDF
Cited by 12
OpenAlex
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes PDF
Cited by 9
OpenAlex
S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes PDF
Cited by 11
OpenAlex
Cohort differences in levels and health effects of aging self-perceptions among older Japanese OA
Cited by 0
Semantic Scholar
Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients PDF
Cited by 28
OpenAlex
Expression of CD44, CD44v9, ABCG2, CD24, Bmi‑1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors PDF
Cited by 36
OpenAlex
Enhanced Expression of Long Non-Coding RNA HOTAIR Is Associated with the Development of Gastric Cancer PDF
Cited by 250
OpenAlex
Research Topics
Immunotherapy and Immune Responses
(11)
Cancer Immunotherapy and Biomarkers
(5)
T-cell and B-cell Immunology
(4)
SARS-CoV-2 and COVID-19 Research
(4)
Lung Cancer Treatments and Mutations
(4)
Affiliations
Tokyo Medical and Dental University
Wakayama Medical University
Ube Frontier University
Japan Science and Technology Agency
Soka University